Nutex Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
34.2%projected annual EPS growth
Analyst Coverage
5analysts covering
FY Revenue (est.)
$871.5Mnext fiscal year
FY EPS (est.)
$28.03next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 13 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Hospital Division Visits Quarterly49.7K
Independent Dispute Resolution (IDR) Win Rate Quarterly85.0%
IDR Award Collection Rate Quarterly80.0%
Watch Items
- Arbitration-related costs as a percentage of arbitration-related revenueTrigger: Exceeding 35%Action: Evaluate efficiency of third-party IDR vendor and assess billing submission workflows.
- Accrued arbitration expensesTrigger: Exceeding $60.0 millionAction: Review cash collection timelines and liquidity reserves to ensure working capital stability.
Research as of 20 Jun 2026